ATE427953T1 - Fondaparinux- natrium zusammenstellung von hoher reinheit - Google Patents
Fondaparinux- natrium zusammenstellung von hoher reinheitInfo
- Publication number
- ATE427953T1 ATE427953T1 AT04710418T AT04710418T ATE427953T1 AT E427953 T1 ATE427953 T1 AT E427953T1 AT 04710418 T AT04710418 T AT 04710418T AT 04710418 T AT04710418 T AT 04710418T AT E427953 T1 ATE427953 T1 AT E427953T1
- Authority
- AT
- Austria
- Prior art keywords
- fondaparinux
- high purity
- sodium composition
- sodium
- composition
- Prior art date
Links
- XEKSTYNIJLDDAZ-JASSWCPGSA-F fondaparinux sodium Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].O[C@@H]1[C@@H](NS([O-])(=O)=O)[C@@H](OC)O[C@H](COS([O-])(=O)=O)[C@H]1O[C@H]1[C@H](OS([O-])(=O)=O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](OS([O-])(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](COS([O-])(=O)=O)O4)NS([O-])(=O)=O)[C@H](O3)C(O)=O)O)[C@@H](COS([O-])(=O)=O)O2)NS([O-])(=O)=O)[C@H](C(O)=O)O1 XEKSTYNIJLDDAZ-JASSWCPGSA-F 0.000 title 1
- 229960003661 fondaparinux sodium Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37526803A | 2003-02-27 | 2003-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE427953T1 true ATE427953T1 (de) | 2009-04-15 |
Family
ID=32961215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04710418T ATE427953T1 (de) | 2003-02-27 | 2004-02-12 | Fondaparinux- natrium zusammenstellung von hoher reinheit |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20050020536A1 (de) |
| EP (1) | EP1625135B1 (de) |
| JP (1) | JP4594298B2 (de) |
| AR (1) | AR044200A1 (de) |
| AT (1) | ATE427953T1 (de) |
| CY (1) | CY1109168T1 (de) |
| DE (1) | DE602004020459D1 (de) |
| DK (1) | DK1625135T3 (de) |
| ES (1) | ES2322464T3 (de) |
| PT (1) | PT1625135E (de) |
| SI (1) | SI1625135T1 (de) |
| TW (1) | TWI335224B (de) |
| WO (1) | WO2004078105A2 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040171819A1 (en) | 2002-10-10 | 2004-09-02 | Aventis Pharma S.A. | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| AU2006244563B2 (en) * | 2005-05-05 | 2011-07-21 | Nyse Group, Inc. | Anti-internalization order modifier |
| US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
| WO2010132616A1 (en) * | 2009-05-12 | 2010-11-18 | Rsa Protective Technologies, Llc | Surface mount vehicle anti-ram security systems |
| CN104245718B (zh) | 2009-07-31 | 2016-11-09 | 可靠生物医药公司 | 制备磺达肝素钠的方法及其合成中使用的中间体 |
| US8420790B2 (en) | 2009-10-30 | 2013-04-16 | Reliable Biopharmaceutical Corporation | Efficient and scalable process for the manufacture of Fondaparinux sodium |
| US20130005954A1 (en) * | 2011-06-28 | 2013-01-03 | Apicore, Llc | Process for preparing heparinoids and intermediates useful in the synthesis thereof |
| CN102659859B (zh) * | 2012-04-11 | 2014-12-10 | 苏州纳微科技有限公司 | 单分散聚甲基丙烯酸酯离子交换层析介质在磺达肝癸钠柱层析纯化中的应用 |
| CN103570774B (zh) * | 2012-08-07 | 2017-08-25 | 博瑞生物医药（苏州）股份有限公司 | 一种戊糖化合物的纯化方法 |
| HK1213585A1 (zh) | 2012-10-22 | 2016-07-08 | Cydex Pharmaceuticals, Inc. | 烷基化环糊精组合物及其制备和使用方法 |
| CN103864862B (zh) * | 2012-12-14 | 2017-10-17 | 博瑞生物医药（苏州）股份有限公司 | 一种戊糖化合物的纯化方法 |
| US9346844B2 (en) | 2013-07-25 | 2016-05-24 | Scinopharm Taiwan, Ltd. | Process for the production of fondaparinux sodium |
| US10072039B2 (en) | 2013-07-25 | 2018-09-11 | Scinopharm Taiwan, Ltd. | Process for the production of Fondaparinux sodium |
| KR20160036606A (ko) * | 2013-07-25 | 2016-04-04 | 시노팜 타이완 리미티드 | 폰다파리눅스 소듐의 제조 방법 |
| CN103992364B (zh) * | 2014-03-25 | 2016-08-10 | 南京天翔医药科技有限公司 | 一种磺达肝癸钠的分离提取方法 |
| CN103965269B (zh) * | 2014-04-16 | 2018-05-04 | 杭州华东医药集团新药研究院有限公司 | 低水分高纯度的磺达肝癸钠及其制备方法 |
| US9873712B2 (en) * | 2014-10-03 | 2018-01-23 | Amphastar Pharmaceuticals, Inc. | Method of purifying idraparinux sodium |
| US10688249B2 (en) * | 2015-06-11 | 2020-06-23 | Virchow Biotech Pvt. Ltd. | Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same |
| CN104910217B (zh) * | 2015-06-19 | 2018-04-17 | 天津红日药业股份有限公司 | 用于磺达肝癸钠质量控制的参比化合物 |
| CN105037452B (zh) * | 2015-06-19 | 2018-10-09 | 天津红日药业股份有限公司 | 一种快速制备高纯度磺达肝癸钠的精制方法 |
| CN107501359B (zh) * | 2017-08-24 | 2020-07-31 | 深圳市海滨制药有限公司 | 一种磺达肝癸钠杂质化合物及其制备方法与应用 |
| CN114478663B (zh) * | 2020-11-12 | 2023-12-01 | 杭州中美华东制药有限公司 | 一种磺达肝癸钠杂质的制备方法 |
| CN114591379A (zh) * | 2021-12-30 | 2022-06-07 | 淮北师范大学 | 一种磺达肝癸钠甲酰化杂质的制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE664087A (de) * | 1956-03-29 | |||
| US4025357A (en) * | 1975-04-14 | 1977-05-24 | A. E. Staley Manufacturing Company | Ion exchange enrichment of impure dextrose solutions |
| JPS5577896A (en) * | 1978-12-07 | 1980-06-12 | Meiji Seika Kaisha Ltd | Preparation of high-purity maltose |
| FR2456116A1 (fr) * | 1979-05-11 | 1980-12-05 | Sarget Lab | Nouvelle saponine triterpenique derivee de la caulophyllogenine et ses applications therapeutiques |
| US4242501A (en) * | 1979-08-08 | 1980-12-30 | American Cyanamid Company | Purification of pneumococcal capsular polysaccharides |
| US4502890A (en) * | 1981-03-02 | 1985-03-05 | Calgon Carbon Corporation | Purification of sugar liquors with activated carbon |
| DE3118588C2 (de) * | 1981-05-11 | 1983-07-07 | Luitpold-Werk, Chemisch-Pharmazeutische Fabrik, 8000 München | Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung |
| JPS5899497A (ja) * | 1981-11-27 | 1983-06-13 | Snow Brand Milk Prod Co Ltd | 新規なオリゴ糖、その製造法及びビフイドバクテリウム菌の増殖促進剤 |
| JPS60102196A (ja) * | 1983-11-07 | 1985-06-06 | Daicel Chem Ind Ltd | 粗グリコシドの精製処理方法 |
| US4686102A (en) * | 1984-04-12 | 1987-08-11 | American Cyanamid Company | Multivalent pneumococcal vaccine and preparation thereof |
| JPS61118336A (ja) * | 1984-11-13 | 1986-06-05 | Yonezawa Kagaku Kogyo Kk | ペンタクロルフエノ−ル及びその誘導体の精製法 |
| JPH0673442B2 (ja) * | 1986-03-13 | 1994-09-21 | 明治製菓株式会社 | 食品の老化防止方法 |
| SE453394B (sv) * | 1986-07-07 | 1988-02-01 | Pharmacia Ab | Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen |
| JPS6398395A (ja) * | 1986-10-16 | 1988-04-28 | Katakura Chitsukarin Kk | キトサンオリゴ糖の製造法 |
| US5756721A (en) * | 1991-01-16 | 1998-05-26 | National Starch And Chemical Investment Holding Corporation | Purification of polysaccharides |
| US5569756A (en) * | 1995-03-21 | 1996-10-29 | American Maize-Products Company | Purification of chemically modified cyclodextrins |
| DE19543052A1 (de) * | 1995-11-06 | 1997-05-07 | Schering Ag | Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren |
| EP1235783B1 (de) * | 1999-08-30 | 2004-09-29 | Mossi & Ghisolfi International S.A. | Verfahren zur trennung des dikaliumsalzes der naphthalenedicarbonsäure mittels betten von aktivierter kohle |
-
2004
- 2004-02-12 DE DE602004020459T patent/DE602004020459D1/de not_active Expired - Lifetime
- 2004-02-12 DK DK04710418T patent/DK1625135T3/da active
- 2004-02-12 WO PCT/FR2004/000314 patent/WO2004078105A2/fr not_active Ceased
- 2004-02-12 JP JP2006505669A patent/JP4594298B2/ja not_active Expired - Fee Related
- 2004-02-12 PT PT04710418T patent/PT1625135E/pt unknown
- 2004-02-12 AT AT04710418T patent/ATE427953T1/de active
- 2004-02-12 SI SI200431107T patent/SI1625135T1/sl unknown
- 2004-02-12 EP EP04710418A patent/EP1625135B1/de not_active Expired - Lifetime
- 2004-02-12 ES ES04710418T patent/ES2322464T3/es not_active Expired - Lifetime
- 2004-02-19 AR ARP040100513A patent/AR044200A1/es not_active Application Discontinuation
- 2004-02-19 TW TW093104096A patent/TWI335224B/zh not_active IP Right Cessation
- 2004-06-30 US US10/881,250 patent/US20050020536A1/en not_active Abandoned
-
2009
- 2009-06-18 CY CY20091100645T patent/CY1109168T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1109168T1 (el) | 2014-07-02 |
| AR044200A1 (es) | 2005-09-07 |
| EP1625135B1 (de) | 2009-04-08 |
| DK1625135T3 (da) | 2009-06-22 |
| JP2006519246A (ja) | 2006-08-24 |
| ES2322464T3 (es) | 2009-06-22 |
| PT1625135E (pt) | 2009-07-10 |
| TWI335224B (en) | 2011-01-01 |
| WO2004078105A3 (fr) | 2004-10-28 |
| JP4594298B2 (ja) | 2010-12-08 |
| EP1625135A2 (de) | 2006-02-15 |
| HK1087719A1 (zh) | 2006-10-20 |
| US20050020536A1 (en) | 2005-01-27 |
| WO2004078105A2 (fr) | 2004-09-16 |
| SI1625135T1 (sl) | 2009-08-31 |
| DE602004020459D1 (de) | 2009-05-20 |
| TW200501965A (en) | 2005-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE427953T1 (de) | Fondaparinux- natrium zusammenstellung von hoher reinheit | |
| ATE488224T1 (de) | Aerosol-formulierungen von diisobutyryl apomorphine | |
| DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
| DE602004000740D1 (de) | Herstellung von Nuten | |
| DE602004031992D1 (de) | Herstellung von elektronischen Geräten | |
| DK1522539T3 (da) | Krystallinsk komposition indeholdende excitalopram | |
| DE10393374D2 (de) | Zusammensetzung | |
| BRPI0313075A2 (pt) | composições de vidro | |
| EP1559433A4 (de) | Stabilisierte zusammensetzung | |
| ATE364610T1 (de) | Kristalline polymorphe form von irinotecan- hyrochlorid | |
| DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
| DK1492934T3 (da) | Dørenhed | |
| DE602004023786D1 (de) | Herstellung von hochreinem Alkylgallium | |
| ITMI20021038A0 (it) | Disposizione di elettrodi | |
| CY1111081T1 (el) | Νεα μεθοδος συνθεσης του (7-μεθοξυ-1-ναφθυλ) ακετονιτριλιου και εφαρμογη στη συνθεση της αγκομελατινης | |
| FI20030466L (fi) | Liimausainekoostumus | |
| DE60327426D1 (de) | Markierung von substraten | |
| DE50311406D1 (de) | Verwendung von Formkörpern | |
| ATE474824T1 (de) | Herstellung von olefinen | |
| EP1689431A4 (de) | Zytoprotektive wirkungen von ethylpyruvat | |
| DE602004016734D1 (de) | Flüssigkristalline zusammensetzung | |
| DE602004031534D1 (de) | Stabiler polymorph von bifeprunoxmesilat | |
| ITPA20030031A1 (it) | Composizioni che contengono acido l-ascorbico stabilizzato | |
| NO20044140D0 (no) | New Composition | |
| DE50203046D1 (de) | Verwendung von Esterquats |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1625135 Country of ref document: EP |